Tomás Berl

Q: What Schools Are Affiliated With Tomás Berl

Tomás Berl is affiliated with the following schools: University of Colorado Denver, University of California, San Francisco

Tomás Berl's AcademicInfluence.com Rankings

Tomás Berl

Engineering

#6478

World Rank

#7809

Historical Rank

Biomedical Engineering

#580

World Rank

#590

Historical Rank

engineering Degrees

Tomás Berl

Philosophy

#8800

World Rank

#12249

Historical Rank

Logic

#5818

World Rank

#7258

Historical Rank

philosophy Degrees

Download Badge

Engineering
Philosophy

Tomás Berl's Degrees

PhD Biomedical Engineering University of California, Berkeley
Doctorate Medicine University of California, San Francisco

Why Is Tomás Berl Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Tomás Berl's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. (2001) (5564)
Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia. (2006) (1133)
Cardio-renal syndromes: report from the consensus conference of the Acute Dialysis Quality Initiative (2009) (874)
The Syndrome of Inappropriate Antidiuresis (2007) (604)
Pathogenesis of Diabetic Nephropathy (2004) (505)
Osmotic and nonosmotic control of vasopressin release. (1979) (485)
Cardiovascular Outcomes in the Irbesartan Diabetic Nephropathy Trial of Patients with Type 2 Diabetes and Overt Nephropathy (2003) (404)
Clinical practice. The syndrome of inappropriate antidiuresis. (2007) (400)
Radioimmunoassay of plasma arginine vasopressin in hyponatremic patients with congestive heart failure. (1981) (379)
Impact of achieved blood pressure on cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial. (2005) (332)
Oral tolvaptan is safe and effective in chronic hyponatremia. (2010) (317)
Hyponatremia in cirrhosis: From pathogenesis to treatment (1998) (282)
Evidence for an in vivo antagonism between vasopressin and prostaglandin in the mammalian kidney. (1975) (265)
Predictors of the progression of renal insufficiency in patients with insulin-dependent diabetes and overt diabetic nephropathy. The Collaborative Study Group. (1996) (226)
Randomized Placebo-Controlled EPPIC Trials of AST-120 in CKD. (2015) (212)
Kidney-heart interactions: epidemiology, pathogenesis, and treatment. (2005) (208)
American Society of Nephrology Renal Research Report. (2005) (196)
Epidemiology of cardio-renal syndromes: workgroup statements from the 7th ADQI Consensus Conference. (2010) (192)
Prostaglandins: effects on blood pressure, renal blood flow, sodium and water excretion. (1976) (189)
A multicenter, randomized, double-blind, placebo-controlled, dose-ranging study of AST-120 (Kremezin) in patients with moderate to severe CKD. (2006) (185)
Effect of intensive blood pressure control on the course of type 1 diabetic nephropathy. Collaborative Study Group. (1999) (181)
Treating hyponatremia: damned if we do and damned if we don't. (1990) (176)
Efficacy and safety of oral tolvaptan therapy in patients with the syndrome of inappropriate antidiuretic hormone secretion. (2011) (162)
Pyridorin in type 2 diabetic nephropathy. (2012) (141)
Impact of solute intake on urine flow and water excretion. (2008) (136)
Sulodexide fails to demonstrate renoprotection in overt type 2 diabetic nephropathy. (2012) (129)
Sodium (1998) (127)
Predictors of cardiovascular events in patients with type 2 diabetic nephropathy and hypertension: a case for albuminuria. (2004) (125)
Determinants of survival and recovery in acute renal failure patients dialyzed in intensive-care units. (1991) (125)
Cardiorenal syndromes: an executive summary from the consensus conference of the Acute Dialysis Quality Initiative (ADQI). (2010) (124)
Albuminuria and blood pressure, independent targets for cardioprotective therapy in patients with diabetes and nephropathy: a post hoc analysis of the combined RENAAL and IDNT trials. (2011) (124)
MAPK Mediation of Hypertonicity-stimulated Cyclooxygenase-2 Expression in Renal Medullary Collecting Duct Cells* (2000) (121)
Different ways to die: cell death modes of the unicellular chlorophyte Dunaliella viridis exposed to various environmental stresses are mediated by the caspase-like activity DEVDase (2009) (119)
In vivo effect of indomethacin to potentiate the renal medullary cyclic AMP response to vasopressin. (1977) (119)
Nonosmolar factors affecting renal water excretion (second of two parts). (1975) (118)
Sulodexide for kidney protection in type 2 diabetes patients with microalbuminuria: a randomized controlled trial. (2011) (117)
Definition and classification of Cardio-Renal Syndromes: workgroup statements from the 7th ADQI Consensus Conference. (2010) (116)
The role of renal nerves and prostaglandins in control of renal hemodynamics and plasma renin activity during hypotensive hemorrhage in the dog. (1978) (114)
Role of vasopressin in the impaired water excretion of glucocorticoid deficiency. (1980) (103)
Clinical disorders of water metabolism. (1976) (100)
"Beer potomania" in non-beer drinkers: effect of low dietary solute intake. (1998) (99)
1,25 dihydroxycholecalciferol effects in chronic dialysis. A double-blind controlled study. (1978) (97)
Syndrome of inappropriate secretion of antidiuretic hormone with exacerbated psychosis. (1973) (95)
On the mechanism of polyuria in potassium depletion. The role of polydipsia. (1977) (90)
Mechanism of effect of alpha adrenergic stimulation with norepinephrine on renal water excretion. (1973) (90)
Role of aldosterone in the control of sodium excretion in patients with advanced chronic renal failure. (1978) (88)
Plasmapheresis does not increase the risk for infection in immunosuppressed patients with severe lupus nephritis. The Lupus Nephritis Collaborative Study Group. (1991) (83)
Renal toxicity in uranium mill workers. (1985) (83)
Dominant-Negative c-Jun NH2-terminal Kinase 2 Sensitizes Renal Inner Medullary Collecting Duct Cells to Hypertonicity-induced Lethality Independent of Organic Osmolyte Transport* (1998) (83)
Multiple mitogen-activated protein kinases are regulated by hyperosmolality in mouse IMCD cells. (1997) (82)
The hyponatremic patient: practical focus on therapy. (1997) (80)
Mechanism of suppression of vasopressin during alpha-adrenergic stimulation with norepinephrine. (1974) (80)
Efficacy and Safety of Carvedilol in Treatment of Heart Failure with Chronic Kidney Disease: A Meta-Analysis of Randomized Trials (2011) (77)
Serum Cystatin C Predicts Progression of Subclinical Coronary Atherosclerosis in Individuals With Type 1 Diabetes (2007) (75)
Review: Renal protection by inhibition of the renin-angiotensin-aldosterone system (2009) (75)
Mechanism of the antidiuretic effect associated with interruption of parasympathetic pathways. (1972) (73)
Prostaglandins in the beta-adrenergic and baroreceptor-mediated secretion of renin. (1979) (73)
A patient with severe hyponatremia and hypokalemia: osmotic demyelination following potassium repletion. (2010) (71)
Mechanism of effect of prostaglandin E 1 on renal water excretion. (1973) (63)
Mechanism of stimulation of vasopressin release during beta adrenergic stimulation with isoproterenol. (1974) (60)
Altered water metabolism in tuberculosis: role of vasopressin. (1990) (57)
Mechanism of effect of nicotine on renal water excretion. (1974) (57)
Dysnatremias in patients with kidney disease. (2014) (54)
The Expression of Aquaporin-1 in the Medulla of the Kidney Is Dependent on the Transcription Factor Associated with Hypertonicity, TonEBP (2010) (54)
Role of antidiuretic hormone in impaired urinary dilution associated with chronic bile-duct ligation. (1980) (52)
Phosphorylation of MAP kinase-like proteins mediate the response of the halotolerant alga Dunaliella viridis to hypertonic shock. (2004) (50)
Pharmacokinetics of fluconazole in renal failure. (1995) (48)
Angiotensin II, renal nerves, and prostaglandins in renal hemodynamics during hemorrhage. (1978) (48)
Hypertonic stress increases claudin-4 expression and tight junction integrity in association with MUPP1 in IMCD3 cells (2008) (47)
Long-term adaptation of renal cells to hypertonicity: role of MAP kinases and Na-K-ATPase. (2001) (46)
Treating hyponatremia: what is all the controversy about? (1990) (46)
The tight junction protein, MUPP1, is up-regulated by hypertonicity and is important in the osmotic stress response in kidney cells (2007) (46)
The expression of the γ subunit of Na-K-ATPase is regulated by osmolality via C-terminal Jun kinase and phosphatidylinositol 3-kinase-dependent mechanisms (2001) (45)
Mild Chronic Hyponatremia in the Ambulatory Setting: Significance and Management. (2015) (45)
Nonosmolar factors affecting renal water excretion (first of two parts). (1975) (44)
A colorimetric assay for determination of cell viability in algal cultures. (2003) (41)
Hypercalcemia of acute renal failure. Clinical significance and pathogenesis. (1976) (41)
Hormonal control of renal water excretion. (1976) (40)
The effects of AST-120 on chronic kidney disease progression in the United States of America: a post hoc subgroup analysis of randomized controlled trials (2016) (40)
Lower progression rate of end-stage renal disease in patients with peripheral arterial disease using statins or Angiotensin-converting enzyme inhibitors. (2007) (39)
Angiotensin-converting enzyme inhibitors versus AT1 receptor antagonist in cardiovascular and renal protection: the case for AT1 receptor antagonist. (2004) (38)
ADQI 7: the clinical management of the Cardio-Renal syndromes: work group statements from the 7th ADQI consensus conference. (2010) (38)
p38 MAP kinase modulates liver cell volume through inhibition of membrane Na+ permeability. (2001) (37)
Serum Cystatin C Predicts Progression of Subclinical Coronary Atherosclerosis in Individuals With Type 1 (2007) (37)
Epidermal growth factor-stimulated phosphoinositide hydrolysis in cultured rat inner medullary collecting tubule cells. Regulation by G protein, calcium, and protein kinase C. (1990) (36)
Mechanisms of renin secretion during hemorrhage in the dog. (1979) (35)
Disorders of Water Metabolism (2013) (35)
Chloride, not sodium, stimulates expression of the γ subunit of Na/K-ATPase and activates JNK in response to hypertonicity in mouse IMCD3 cells (2003) (34)
Differential diagnosis of hyponatraemia. (2012) (34)
Care of undocumented individuals with ESRD: a national survey of US nephrologists. (2009) (34)
Where vaptans do and do not fit in the treatment of hyponatremia. (2013) (34)
Effects of calcium on vasopressin-mediated cyclic adenosine monophosphate formation in cultured rat inner medullary collecting tubule cells. Evidence for the role of intracellular calcium. (1986) (33)
Prevention of cardio-renal syndromes: workgroup statements from the 7th ADQI Consensus Conference. (2010) (33)
Cell division in the unicellular microalga Dunaliella viridis depends on phosphorylation of extracellular signal-regulated kinases (ERKs). (2007) (32)
ANP stimulates phospholipase C in cultured RIMCT cells: roles of protein kinases and G protein. (1991) (31)
Syndrome of inappropriate antidiuresis in the absence of arginine vasopressin. (1986) (31)
Long-term outcomes after coronary artery bypass grafting: preoperative kidney function is prognostic. (2007) (30)
The Adrogue-Madias formula revisited. (2007) (30)
Catecholamines and renal water excretion. (1975) (30)
In vivo regulation of MAP kinases in Ratus norvegicus renal papilla by water loading and restriction. (1998) (30)
An initial reduction in serum uric acid during angiotensin receptor blocker treatment is associated with cardiovascular protection: a post-hoc analysis of the RENAAL and IDNT trials (2012) (29)
Risk factors for progression of chronic kidney disease in the EPPIC trials and the effect of AST-120 (2017) (29)
Expression of the Calcium-binding Protein S100A4 Is Markedly Up-regulated by Osmotic Stress and Is Involved in the Renal Osmoadaptive Response* (2007) (29)
Effect of alpha- and beta-adrenergic stimulation on renal water excretion in man. (1974) (28)
Hormonal regulation of MAP kinase in cultured rat inner medullary collecting tubule cells. (1994) (27)
Adrenergic control of cAMP generation in rat inner medullary collecting tubule cells. (1989) (22)
Psychosis and water balance. (1988) (22)
Chapter 29 – Therapy of Dysnatremic Disorders (2008) (22)
Vasopressin Receptor Antagonists in Hyponatremia: Uses and Misuses (2017) (20)
Nucleoporin 88 (Nup88) Is Regulated by Hypertonic Stress in Kidney Cells to Retain the Transcription Factor Tonicity Enhancer-binding Protein (TonEBP) in the Nucleus* (2008) (19)
Vasopressin antagonists. (2015) (19)
Myo-inositol uptake by rat cultured inner medullary collecting tubule cells: effect of osmolality. (1991) (19)
Clinically unrecognized Q-wave myocardial infarction in patients with diabetes mellitus, systemic hypertension, and nephropathy. (2004) (19)
An elderly patient with chronic hyponatremia. (2013) (19)
Angiotensin converting enzyme inhibition in diabetic nephropathy (1994) (19)
Maximizing inhibition of the renin-angiotensin system with high doses of converting enzyme inhibitors or angiotensin receptor blockers. (2008) (18)
Adaptation of Murine Inner Medullary Collecting Duct (IMCD3) Cell Cultures to Hypertonicity (2003) (17)
Effects of prostacyclin on the cAMP system in cultured rat inner medullary collecting duct cells. (1990) (17)
The gamma subunit of Na/K-ATPase: an exceptional, small transmembrane protein. (2005) (16)
THE ROLE OF POLYDIPSIA (1977) (16)
Regulation of atrial natriuretic peptide-stimulated cGMP production in the inner medulla. (1992) (15)
Effect of cAMP on prostaglandin E2 production in cultured rat inner medullary collecting tubule cells. (1986) (15)
Severe metabolic alkalosis caused by administration of plasma protein fraction in end-stage renal failure. (1979) (15)
Increased cytosolic Ca2+ inhibits AVP-stimulated adenylyl cyclase activity in rat IMCT cells by activation of PKC. (1994) (15)
Controlled trial of the effects of 1,25-dihydroxycholecalciferol in patients treated with regular dialysis. (1980) (14)
Nephrology core curriculum. The American Society of Nephrology and the American Society of Nephrology Training Program Directors Committee. (1997) (13)
How do kidney cells adapt to survive in hypertonic inner medulla? (2009) (13)
In vivo effect of cellular calcium uptake on osmotic and nonosmotic release of arginine vasopressin. (1982) (13)
Synthesis of the Na-K-ATPase gamma-subunit is regulated at both the transcriptional and translational levels in IMCD3 cells. (2005) (13)
The gamma-subunit of Na-K-ATPase is incorporated into plasma membranes of mouse IMCD3 cells in response to hypertonicity. (2005) (13)
Vasopressin antagonists in the treatment of water-retaining disorders. (2008) (13)
A Metabonomic and Proteomic Analysis of Changes in IMCD3 Cells Chronically Adapted to Hypertonicity (2008) (12)
Vasopressin receptor antagonists: Characteristics and clinical role. (2016) (12)
A Controlled Clinical Trial of Angiotensin-Converting Enzyme Inhibition in Type I Diabetic Nephropathy: Study Design and Patient Characteristics (1992) (12)
Relationship between cystatin C and coronary artery atherosclerosis progression differs by type 1 diabetes. (2010) (12)
Parasympathetic pathways, renin secretion and vasopressin release. (1975) (11)
Water channels in health and disease. (1998) (11)
The effect of anesthesia on hemodynamics and renal function in the rat (1980) (11)
A molecular map of G protein alpha chains in microdissected rat nephron segments. (1993) (10)
ZAC1 Is Up-regulated by Hypertonicity and Decreases Sorbitol Dehydrogenase Expression, Allowing Accumulation of Sorbitol in Kidney Cells* (2009) (10)
Physiology and Pathophysiology of Water Homeostasis. (2019) (10)
Evaluation and management of severe hyponatremia. (1996) (10)
Silencing and overexpression of the gamma-subunit of Na-K-ATPase directly affect survival of IMCD3 cells in response to hypertonic stress. (2006) (9)
Preclinical pharmacologic basis for clinical use of rhIL-11 as an effective platelet-support agent. (2000) (8)
Chronic kidney disease: Mortality and serum sodium in CKD—yet another U-shaped curve (2012) (8)
Is osmotic demyelination a concern dialyzing hyponatremic patients? (2011) (8)
Potassium-aldosterone response in dogs with chronic renal insufficiency. (1985) (8)
Nicardipine and propranolol in the treatment of essential hypertension. (1989) (7)
American Society of Nephrology Presidential Address 2005. (2006) (7)
Expression of GTPase-deficient Ras inhibits vasopressin signaling in cultured cortical collecting duct cells. (1995) (6)
Chronic Lactic Acidosis in a Patient With Acquired Immunodeficiency Syndrome and Mitochondrial Myopathy: Biochemical Studies1 (1992) (5)
D017 Multi-center collaborative trial of angiotensin II receptor antagonism on morbidity, mortality and renal function in hypertensive type II diabetic patients with nephropathy (1998) (5)
Temperature and fluid balance. (1976) (5)
ROLE OF VASOPRESSEN IN THE CONTROL OF SYSTEMIC HEMODYNAMICS—LESSONS LEARNED FROM THE BRATTLEBORO RAT (1982) (5)
Effects of 2-bromoethanamine on TonEBP expression and its possible role in induction of renal papillary necrosis in mice. (2010) (4)
Control of prostaglandin E2 synthesis in cultured rat inner medullary collecting tubule cells: the role of calcium. (1986) (4)
Disorders of sodium balance (1998) (4)
Mannitol: a therapeutic alternative in the treatment of acute hyponatremia? (2000) (4)
Non-osmotic regulation of renal water excretion. (1976) (4)
Vasopressin Antagonists. (2015) (3)
Acute renal failure in pregnancy (1981) (3)
Physiology of Water Balance and Pathophysiology of Hyponatremia (2013) (3)
Letter: Water intoxication and psychosis. In comment. (1974) (3)
DISORDERS OF SODIUM BALANCE. AUTHORS' REPLY (1998) (3)
Mechanism of stimulation of vasopressin (ADH) release during beta adrenergic stimulation with isoproterenol (ISO) (1974) (2)
Mitochondrial respiration and mitochondrial calcium in acute renal failure (1982) (2)
Plasma arginine vasopressin in hyponatremic patients with heart failure. (1981) (2)
On the adaptation of renal cells to hypertonicity. (2000) (2)
Protective effect of renal denervation (RD) and angiotensin II antagonism (AIIA) during hypotensive hemorrhage (HH) in prostaglandin (PG) depleted dogs (1977) (1)
Serum Cystatin C Predicts Progression of Subclinical Coronary Atherosclerosis in Persons with Type 1 Diabetes Mellitus (2007) (1)
Evaluation of effect of angiotensin II (Angio) on renal water excretion (1973) (1)
Humoral, Neural and Hemodynamic Influences on Renal Water Excretion1 (1977) (1)
Disorders of water, electrolytes, and acid-base . Acute renal failure (1999) (1)
Acute Renal Failure and the MELAS Syndrome , a Mitochondrial Encephalomyopathy 1 (2005) (0)
Thanks to Reviewers—2020 (2020) (0)
TonEBP Transcription Factor Associated with Medulla of the Kidney Is Dependent on the The Expression of Aquaporin-1 in the Cell Biology : (2010) (0)
Medullary Sponge Kidney Associated with Congenital Hem ihypertrophy (1996) (0)
Abstract 2730: Results from the SALT 1 and 2 Trials: Multicenter, Randomized, Placebo-controlled Trials in Patients with Euvolemic and Hypervolemic Hyponatremia (2006) (0)
releaseand nonosmotic control of vasopressin (2016) (0)
In memoriam: Robert W. Schrier, 1936-2021. (2021) (0)
Treatment of Hypoosmolar and Hyperosmolar States (1984) (0)
CHAPTER 8 – Disorders of Water Metabolism (2010) (0)
DESCRIPTION OF THE NEPHROLOGY-HYPERTENSION TRAINING PROGRAM AT THE UNIVERSITY OF CALIFORNIA SAN DIEGO, SCHOOL OF MEDICINE (1995) (0)
Nucleus Enhancer-binding Protein ( TonEBP ) in the the Transcription Factor Tonicity RetainHypertonic Stress in Kidney Cells to Nucleoporin 88 ( Nup 88 ) Is Regulated by Mechanisms of Signal Transduction : (2008) (0)
Attending Rounds An Elderly Patient with Chronic Hyponatremia (2013) (0)
PHYSIOLOGY OF BEER OR NON-BEER POTOMANIA. AUTHOR'S REPLY (1998) (0)
Obituary for Robert Schrier. (2021) (0)
Hyponatremia and hypernatremia (2012) (0)
Autosomal Recessive Polycystic Kidney Disease: Issues Regarding the Variability of Clinical Presentation1 (1993) (0)
The authors reply [12] (2007) (0)
Pharmacokinetics of Fluconazole in Renal Failure1 (2005) (0)
Vasopressin Antagonists in Physiology and Disease (2009) (0)
Catastrophic Secondary Antiphospholipid Syndrome With Concomitant Antithrom bin III Deficiency1 (1995) (0)
Water Metabolism in Chronic Kidney Disease (2015) (0)
1099-89 The incidence of clinically unrecognized myocardial infarction in patients with type 2 diabetes, hypertension, and nephropathy (2004) (0)
Obituary for Robert Schrier. (2021) (0)
Acute Renal Failure and the MELASSyndrome, a Mitochondrial Encephalomyopathy1 (1996) (0)
The use of mycophenolate mofetil as a Cyclosporine sparing agent in liver transplant recipients with progressive renal insufficiency (1999) (0)
Overview of the Problem of Cardiovascular Disease in Patients with Kidney Disease (2005) (0)
Tyrosine kinase regulates liver cell volume through effects on na+ influx and opening of non-selective cation channels (1998) (0)
1,25 Dihydroxycholecalciferol Effects in Chronic Dialysis (2020) (0)
Posttransplant Erythrocytosis:Case Report and Review of Newer Treatment Modalities1 (1993) (0)
Protein kinases in the action of vasopressin. (1997) (0)
OVERVIEW OF THE NEPHROLOGY TRAINING PROGRAM AT DUKE UNIVERSITY MEDICAL CENTER (1995) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Tomás Berl?

Tomás Berl is affiliated with the following schools:

Tomás Berl's Academic­Influence.com Rankings

Tomás Berl's Degrees

Why Is Tomás Berl Influential?

Tomás Berl's Published Works

Published Works

What Schools Are Affiliated With Tomás Berl?

Tomás Berl's AcademicInfluence.com Rankings